The Ruber Juan Bravo University Hospital launches its new Clinical Research Unit in the field of neurology. With special emphasis on stroke and other neurological diseases, this Unit places this hospital at the forefront of medical research in Spain.
He Ruber Juan Bravo University Hospital has launched a Research unit whose objective is to carry out studies and clinical trials in different, fundamentally ictus, diseases neuromuscular (neuropathies, myasthenia gravis, ALS, …), disorders neurodegenerative (multiple sclerosis, Alzheimer’s or Parkinson’s, …), sleep disturbances and headaches.
Dr. González-Valcárcel, Coordinator of the Quirónsalud Madrid Stroke Unit, and Dr. Arroyo, Head of the Department of Neurology
According to the Dr. Rafael Arroyo GonzálezHead of the Department of Neurology, this Unit joins the one that has been operating in the University Hospital Quirónsalud Madridso that both work in a network sharing professionals and resources.
«If we take into account that we have a team of neurologists with vast experience in clinical research, as well as nursing teams specialized in clinical trials and with the enthusiastic support of the Center Management and the Quirónsalud Group, we can proudly state that our team is located in the first line of all Spain in neurological clinical research and more specifically in everything related to stroke and other neurological pathologies“, ensures the Dr. Arroyo.
Research on the stroke prevention
He Dr. Jaime González-ValcárcelCoordinator of the Quirónsalud Madrid Stroke Unit, located in the affirms that the investigation on the stroke prevention develops in two lines: in acute phase (with the aim of preventing the appearance of sequelae in people who have suffered a stroke) and secondary prevention (to prevent new episodes of stroke in people who have already suffered it).
«It is estimated that around 30% of people who have suffered a stroke suffer new episodeswhich gives an idea of the importance of secondary prevention«, affirms the Dr. González-Valcárcel.
In this line, the Neurological Clinical Research Unit is currently involved in a international multicenter trial for secondary prevention, in which the main centers around the world participate in the management of ictus.
The study, in which they have already been included several patientsis already being developed and will continue over the next few months, in which the enrollment of new patients that meet the inclusion criteria.